| Literature DB >> 24913157 |
Ines Moura1, Marc Monot2, Chiara Tani3, Patrizia Spigaglia4, Fabrizio Barbanti1, Nathalie Norais3, Bruno Dupuy2, Emilio Bouza5, Paola Mastrantonio1.
Abstract
Stable resistance to metronidazole in a nontoxigenic Clostridium difficile strain was investigated at both the genomic and proteomic levels. Alterations in the metabolic pathway involving the pyruvate-ferredoxin oxidoreductase were found, suggesting that reduction of metronidazole, required for its activity, may be less efficient in this strain. Proteomic studies also showed a cellular response to oxidative stress.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24913157 PMCID: PMC4135993 DOI: 10.1128/AAC.02350-14
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191